Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Fast-growings companies in Insulin resistance
by Most Patent Filing In 3 Years in the United States in 2022

The Insulin resistance top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 3 Years Insulin resistance Fast-growings in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A condition where the body does not respond to insulin.
#
Company Name
Region
Tech Topics
Total
1
Patent: 11
2
RNA interference,Medicine,Health care,
...[+2]
Patent: 9
3
Mifepristone,Medicine,Health care,
...[+2]
Patent: 7
4
Patent: 6
5
Health care,Tumor initiation,Signaling network,
...[+2]
Patent: 6
6
Patent: 5
7
Health care,Social entrepreneurship,Association (object-oriented programming),
...[+2]
Patent: 5
8
Search engine,Association (object-oriented programming),Biology,
...[+2]
Patent: 4
9
Patent: 4
10
Patent: 3
11
Halda Therapeutics OpCo, Inc.
Patent: 2
12
Health care,Pediatric trauma,Neonatology,
...[+2]
Patent: 2
13
Patent: 2
14
Medicine,Health care,Cardiovascular agent,
...[+2]
Patent: 2
15
Patent: 2
16
Pharmacy,Biomedical sciences,Health policy,
...[+2]
Patent: 2
17
Patent: 2
18
Patent: 2
19
Biosimilar,Pharmacy and Therapeutics,Medicine,
...[+2]
Patent: 2
20
Patent: 2
Page generation time: Jul 18 2025